Against a backdrop of manufacturing prioritisation, Novo Nordisk’s contract with Swiss medical technology Ypsomed could include the supply of injection pens for CagriSema, the former’s ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

28 days Prescribing information 70% insulin aspart protamine suspension and 30% insulin as part injection (rDNA origin) pen fill cartridge Novolog Mix 70/30 pen fill cartridge (Novo Nordisk ...

Posts by the clinics featured images of weight-loss injection pens and direct references to the drugs, violating UK advertising rules. Novo Nordisk denied knowledge of the clinics' promotional ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...